560 related articles for article (PubMed ID: 16682041)
1. The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study.
Martinelli N; Trabetti E; Bassi A; Girelli D; Friso S; Pizzolo F; Sandri M; Malerba G; Pignatti PF; Corrocher R; Olivieri O
Atherosclerosis; 2007 Apr; 191(2):409-17. PubMed ID: 16682041
[TBL] [Abstract][Full Text] [Related]
2. Mutation screening of the APOA5 gene in subjects with coronary artery disease.
Soufi M; Sattler AM; Kurt B; Schaefer JR
J Investig Med; 2012 Oct; 60(7):1015-9. PubMed ID: 22914599
[TBL] [Abstract][Full Text] [Related]
3. A genetic variant c.553G > T in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and altered triglyceride levels in a Chinese population.
Tang Y; Sun P; Guo D; Ferro A; Ji Y; Chen Q; Fan L
Atherosclerosis; 2006 Apr; 185(2):433-7. PubMed ID: 16046221
[TBL] [Abstract][Full Text] [Related]
4. APOA5 genetic variants are markers for classic hyperlipoproteinemia phenotypes and hypertriglyceridemia.
Wang J; Ban MR; Kennedy BA; Anand S; Yusuf S; Huff MW; Pollex RL; Hegele RA
Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):730-7. PubMed ID: 18779834
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein A5 and apolipoprotein C3 single nucleotide polymorphisms are correlated with an increased risk of coronary heart disease: a case-control and meta-analysis study.
Yang G; Lei MM; Yu CL; Liu XX; An Z; Song CL
Lipids Health Dis; 2015 Sep; 14():113. PubMed ID: 26387083
[TBL] [Abstract][Full Text] [Related]
6. Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men.
Dallongeville J; Cottel D; Montaye M; Codron V; Amouyel P; Helbecque N
Int J Cardiol; 2006 Jan; 106(2):152-6. PubMed ID: 16321685
[TBL] [Abstract][Full Text] [Related]
7. SNPs at the APOA5 gene account for the strong association with hypertriglyceridaemia at the APOA5/A4/C3/A1 locus on chromosome 11q23 in the Northern Irish population.
Wright WT; Young IS; Nicholls DP; Patterson C; Lyttle K; Graham CA
Atherosclerosis; 2006 Apr; 185(2):353-60. PubMed ID: 16125709
[TBL] [Abstract][Full Text] [Related]
8. Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism.
Henneman P; Schaap FG; Havekes LM; Rensen PC; Frants RR; van Tol A; Hattori H; Smelt AH; van Dijk KW
Atherosclerosis; 2007 Jul; 193(1):129-34. PubMed ID: 16777114
[TBL] [Abstract][Full Text] [Related]
9. Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome.
Niculescu LS; Vlădică M; Sima AV
Biochem Biophys Res Commun; 2010 Jan; 391(1):587-91. PubMed ID: 19932084
[TBL] [Abstract][Full Text] [Related]
10. Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub-study.
Ariza MJ; Sánchez-Chaparro MA; Barón FJ; Hornos AM; Calvo-Bonacho E; Rioja J; Valdivielso P; Gelpi JA; González-Santos P
BMC Med Genet; 2010 Apr; 11():66. PubMed ID: 20429872
[TBL] [Abstract][Full Text] [Related]
11. Elevated levels of triglyceride and triglyceride-rich lipoprotein triglyceride induced by a high-carbohydrate diet is associated with polymorphisms of APOA5-1131T>C and APOC3-482C>T in Chinese healthy young adults.
Lin J; Fang DZ; Du J; Shigdar S; Xiao LY; Zhou XD; Duan W
Ann Nutr Metab; 2011; 58(2):150-7. PubMed ID: 21646779
[TBL] [Abstract][Full Text] [Related]
12. A genetic variant c.553G > T (rs2075291) in the apolipoprotein A5 gene is associated with altered triglycerides levels in coronary artery disease (CAD) patients with lipid lowering drug.
Bogari NM; Aljohani A; Amin AA; Al-Allaf FA; Dannoun A; Taher MM; Elsayed A; Rednah DI; Elkhatee O; Porqueddu M; Alamanni F; Khogeer SAA; Fawzy A
BMC Cardiovasc Disord; 2019 Jan; 19(1):2. PubMed ID: 30606120
[TBL] [Abstract][Full Text] [Related]
13. The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease.
Jang Y; Paik JK; Hyun YJ; Chae JS; Kim JY; Choi JR; Lee SH; Shin DJ; Ordovas JM; Lee JH
Clin Chim Acta; 2009 Apr; 402(1-2):83-7. PubMed ID: 19159622
[TBL] [Abstract][Full Text] [Related]
14. [Polymorphisms in the apolipoprotein A5 gene and apolipoprotein C3 gene in patients with coronary artery disease].
Bi N; Yan SK; Li GP; Yin ZN; Xue H; Wu G; Chen BS
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Feb; 33(2):116-21. PubMed ID: 15924804
[TBL] [Abstract][Full Text] [Related]
15. The influence of the S19W SNP of the APOA5 gene on triglyceride levels in southern Brazil: interactions with the APOE gene, sex and menopause status.
De Andrade FM; Maluf SW; Schuch JB; Voigt F; Barros AC; Lucatelli JF; Hutz MH
Nutr Metab Cardiovasc Dis; 2011 Aug; 21(8):584-90. PubMed ID: 20304614
[TBL] [Abstract][Full Text] [Related]
16. The effect of APOA5 and APOC3 variants on lipid parameters in European Whites, Indian Asians and Afro-Caribbeans with type 2 diabetes.
Dorfmeister B; Cooper JA; Stephens JW; Ireland H; Hurel SJ; Humphries SE; Talmud PJ
Biochim Biophys Acta; 2007 Mar; 1772(3):355-63. PubMed ID: 17197160
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study.
Hallman DM; Srinivasan SR; Chen W; Boerwinkle E; Berenson GS
Metabolism; 2006 Dec; 55(12):1574-81. PubMed ID: 17142127
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein C3 genetic polymorphisms are associated with lipids and coronary artery disease in a Chinese population.
Cui F; Li K; Li Y; Zhang X; An C
Lipids Health Dis; 2014 Nov; 13():170. PubMed ID: 25380998
[TBL] [Abstract][Full Text] [Related]
19. Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes.
Qi L; Liu S; Rifai N; Hunter D; Hu FB
Atherosclerosis; 2007 May; 192(1):204-10. PubMed ID: 16781717
[TBL] [Abstract][Full Text] [Related]
20. The expression of type III hyperlipoproteinemia: involvement of lipolysis genes.
Henneman P; van der Sman-de Beer F; Moghaddam PH; Huijts P; Stalenhoef AF; Kastelein JJ; van Duijn CM; Havekes LM; Frants RR; van Dijk KW; Smelt AH
Eur J Hum Genet; 2009 May; 17(5):620-8. PubMed ID: 19034316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
